Abstract: The method of decreasing atherosclerosis and its complications, such as, myocardial infarction, stroke and peripheral vascular disease involving administering to a human or animal an amount of finasteride sufficient to decrease atherosclerosis and its complications.
Abstract: A self-propelling aerosol formulation which may be free from CFC's which comprises a medicament, 1,1,1,2-tetrafluoroethane, a surface active agent and at least one compound having a higher polarity than 1,1,1,2-tetrafluoroethane.
Type:
Grant
Filed:
May 31, 1995
Date of Patent:
February 25, 1997
Assignee:
Riker Laboratories, Inc.
Inventors:
Tarlochan S. Purewal, David J. Greenleaf
Abstract: The present invention provides a pharmaceutical granule composition comprising cimetidine and, as a granulating agent and taste-masking agent, an ester of a polyhydroxy compound, and where desired a palatable pharmaceutically acceptable emulsifier. Particular esters are glycerol esters. The granules of the present invention can be used in the preparation of chewable tablets which have good palatability and bioavailability.
Type:
Grant
Filed:
December 20, 1988
Date of Patent:
October 15, 1991
Assignee:
Smith Kline Dauelsberg GmbH
Inventors:
Eberhard F. Gottwald, Hermann P. Osterwald, Horst M. Machoczek, David Mayron